Timeliness of a Signal Detection Process as a Component of Effectiveness Assessment in a Drug Safety Department of a Large Pharmaceutical Company: Review Over a 5-Year Period

In conclusion, the signal detection process at Novartis Pharmaceuticals could detect at least 9 of 10 signals prior to them being detected by health authorities.

Source: Therapeutic Innovation and Regulatory Science - October 30, 2014 Category: Drugs & Pharmacology Authors: Bapatla, K. B., Close, P., Sharma, G., Naidu, M., Valliappan, R. Tags: Product Safety Source Type: research